Home / Insights / Vaxxas Initiates Program With Merck to Optimize Delivery of Next Generation Vaccines Utilizing Novel Mechanism for Immune System Activation

Vaxxas Initiates Program With Merck to Optimize Delivery of Next Generation Vaccines Utilizing Novel Mechanism for Immune System Activation

08 October 2012

Posted in — OneVentures

Share

Learn More

Share

You may also like

18 June 2023

Healthcare

Vaxxas opens world-class manufacturing facility to produce needle-free vaccine patch


06 December 2022

OneVentures

Needle-free vaccine innovator banks $34m


10 November 2021

OneVentures

Vaxxas recognised in the Top 10 healthcare startups in Australia, 2021


View All

Ventured. Gained.
decor